Tuesday 20 March 2012

Methylene Diphenyl Diisocyanate-Clinical Trial Management-Clinical Trials Industry

DATATRAK Exhibits at CBI's 5th Annual Forum on CTMS

CLEVELAND, March 19, 2012 /PRNewswire / -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its attendance at CBI's 5th Annual Forum on Clinical Trial Management Systems... read more..

Methylene Diphenyl Diisocyanate (MDI) Market is Expected to Reach USD 16.0 Billion by 2016: Transparency Market Research

ALBANY, New York, March 19, 2012 /PRNewswire/ --According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Methylene Diphenyl Diisocyanate (MDI) Market: Global Market Analysis, Size, Share & Forecast (2009 - 2016)", Global... read more..

Bone Marrow Transplant Arrests Symptoms in Model of Rett Syndrome

Results Emphasize Immune Component of Autism Spectrum DisorderTRUMBULL, Conn., March 19, 2012 /PRNewswire-USNewswire/ -- A paper published online in Nature describes the results of using bone marrow transplant (BMT) to replace faulty immune system cells in models of Rett Syndrome.... read more..

No comments:

Post a Comment